Bengel Christopher Paul, Kacapor Rifat
Department of Cardiology, Kliniken Frankfurt-Main-Taunus, Bad Soden Hospital, Medizinische Klinik I, Kronberger Str. 36, 65812 Bad Soden, Germany.
Eur Heart J Case Rep. 2022 Jan 9;6(1):ytac004. doi: 10.1093/ehjcr/ytac004. eCollection 2022 Jan.
Vaccination is the most important measure to control the coronavirus disease 2019 (COVID-19) pandemic. Myocarditis has been reported as a rare adverse reaction to COVID-19 vaccines. The clinical presentation of myocarditis in such cases can range from mild general symptoms to acute heart failure.
We report the cases of two young men who presented with chest pain and dyspnoea following the administration of the mRNA COVID-19 vaccine. Cardiac investigations revealed findings typical of acute myocarditis.
Myocarditis is a rare complication following mRNA COVID-19 vaccination. In this case series, the temporal proximity of the development of acute myocarditis and the administration of the mRNA COVID-19 vaccine was acknowledged. In the absence of other causative factors, myocarditis in these patients potentially occurred due to an adverse reaction to the mRNA COVID-19 vaccine. However, a causal relationship remains speculative. Clinical suspicion of myocarditis should be high if patients present with chest pain or dyspnoea after receiving COVID-19 vaccination.
接种疫苗是控制2019冠状病毒病（COVID-19）大流行的最重要措施。心肌炎已被报告为COVID-19疫苗罕见的不良反应。此类病例中心肌炎的临床表现从轻微的全身症状到急性心力衰竭不等。
我们报告了两名年轻男性在接种mRNA COVID-19疫苗后出现胸痛和呼吸困难的病例。心脏检查显示出典型的急性心肌炎表现。
心肌炎是接种mRNA COVID-19疫苗后罕见的并发症。在本病例系列中，承认了急性心肌炎的发生与mRNA COVID-19疫苗接种在时间上的接近性。在没有其他致病因素的情况下，这些患者的心肌炎可能是由于对mRNA COVID-19疫苗的不良反应所致。然而，因果关系仍具有推测性。如果患者在接种COVID-19疫苗后出现胸痛或呼吸困难，临床应高度怀疑心肌炎。
